Reactive hyperemia and tissue-type plasminogen activator release in hypertensive men

Blood Coagulation and Fibrinolysis

Volumn 14, Issue 1, 2003, Pages 19-25

  Dell'Omo, Giulia ^b   De Negri, Ferdinando ^b   Carmassi, Franco ^b   Ruocco, Lucia ^b   Mariani, Mario ^b   Pedrinelli, Roberto ^a  

^a UNIVERSITY OF PISA   (Italy)

^b NONE

Author keywords

Atherosclerotic vascular disease; Bradykinin; Endothelium; Hypertension; Reactive hyperemia; Tissue type plasminogen activator

Indexed keywords

ACETYLCHOLINE; ADENOSINE; BRADYKININ; KININ; KININOGEN; MIOVISIN; MUSCARINIC RECEPTOR; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; AGING; ARTERY; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); DIASTOLIC BLOOD PRESSURE; DRUG INFUSION; ENDOTHELIUM; ENZYME RELEASE; FIBRINOLYSIS; FOREARM BLOOD FLOW; HUMAN; HYPERCHOLESTEROLEMIA; HYPEREMIA; HYPERTENSION; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; VASODILATATION; VEIN;

ACETYLCHOLINE; ADENOSINE; ADULT; AGED; BRADYKININ; FOREARM; HUMANS; HYPERCHOLESTEROLEMIA; HYPEREMIA; HYPERTENSION; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; PERIPHERAL VASCULAR DISEASES; TISSUE PLASMINOGEN ACTIVATOR; VASODILATION;

EID: 12244279033     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200301000-00005     Document Type: Article

References (41)

1. Arnal JF, Dinh-Xuan AT, Pueyo M, Darblade B, Rami J. Endothelium-derived nitric oxide and vascular physiology and pathology. Cell Mol Life Sci 1999; 55:1078-1087.
2. Lijnen HR. Elements of the fibrinolytic system. Ann NY Acad Sci 2001; 936:226-236.
3. Brown NJ, Gainer JV, Murphey LJ, Vaughan DE. Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclo-oxygenase-independent pathway. Circulation 2000; 102:2190-2196.
4. Labinjoh C, Newby DE, Dawson P, Johnston NR, Ludlam CA, Boon NA, Webb DJ. Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in man. Cardiovasc Res 2000; 47:707-714.
5. Newby DE, Wright RA, Labinjoh C, Ludlam CA, Fox KA, Boon NA, Webb DJ. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Circulation 1999; 99:1411-1415.
6. Wall U, Jern S, Tengborn L, Jern C. Evidence of a local mechanism for desmopressin-induced tissue-type plasminogen activator release in human forearm. Blood 1998; 91:529-537.
7. Stein CM, Brown N, Vaughan DE, Lang CC, Wood AJ. Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature. J Am Coll Cardiol 1998; 32:117-122.
8. Newby DE, McLeod AL, Uren NG, Flint L, Ludlam CA, Webb DJ, et al. Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis. Circulation 2001; 103:1936-1941.
9. Monsuez JJ. Mediators of reactive hyperemia. Arch Mal Coeur Vaiss 2001; 94:591-599.
10. Pohl U, De Wit C, Gloe T. Large arterioles in the control of blood flow: role of endothelium-dependent dilation. Acta Physiol Scand 2000; 168:505-510.
11. Meredith IT, Currie KE, Anderson TJ, Roddy MA, Ganz P, Creager MA. Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol 1996; 270:H1435-H1440.
12. Higashi Y, Sasaki S, Sasaki N, Nakagawa K, Ueda T, Yoshimizu A, et al. Daily aerobic exercise improves reactive hyperemia in patients with essential hypertension. Hypertension 1999; 33:591-597.
13. Duffy SJ, New G, Tran BT, Harper RW, Meredith IT. Relative contribution of vasodilator prostanoids and NO to metabolic vasodilation in the human forearm. Am J Physiol 1999; 276:H663-H670.
14. Dakak N, Husain S, Mulcahy D, Andrews NP, Panza JA, Waclawiw M, et al. Contribution of nitric oxide to reactive hyperemia. Impact of endothelial dysfunction. Hypertension 1998; 32:9-15.
15. Lip GY, Li-Saw-Hee FL. Does hypertension confer a hypercoagulable state? J Hypertens 1998; 16:913-916.
16. Carmassi F, Morale M, Ferrini L, Dell'Omo G, Ferdeghini M, Pedrinelli R, De Negri F. Local insulin infusion stimulates expression of plasminogen activator inhibitor-1 and tissue-type plasminogen activator in normal subjects. Am J Med 1999; 107:344-350.
17. Whitney R. The measurement of volume changes in human limbs. J Physiol 1953; 121:1-27.
18. Robertson BR, Pandolfi M, Nilsson IM. 'Fibrinolytic capacity' in healthy volunteers as estimated from effect of venous occlusion of arms. Acta Chir Scand 1972; 138:429-436.
19. Keber D, Blinc A, Fettich J. Increase of tissue plasminogen activator in limbs during venous occlusion: a simple haemodynamic model. Thromb Haemost 1990; 64:433-437.
20. Gough SCL, Smyllie J, Sheldon T, Rice PJS, Grant PJ. The anatomical distribution of plasma fibrinolytic activity in man during cardiac catheterisation. Thromb Haemost 1992; 68:442-447.
21. Folkow B. Intravascular pressure as a factor regulating the tone of the small vessels. Acta Physiol Scand 1949; 17:289-310.
22. Jern C, Selin L, Jern S. In-vivo release of tissue-type plasminogen activator across the human forearm during mental stress. Thromb Haemost 1994; 72:285-291.
23. Smith D, Gilbert M, Owen WG. Tissue plasminogen activator release in vivo in response to vasoactive agents. Blood 1985; 66:835-839.
24. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Kajiyama G, Oshima T. A noninvasive measurement of reactive hyperemia that can be used to assess resistance artery endothelial function in humans. Am J Cardiol 2001; 87:121-125.
25. Zelis R, Mason DT, Braunwald E, Levy RI. Effects of hyperlipoproteinemias and their treatment on the peripheral circulation. J Clin Invest 1970; 49:1007-1015.
26. Hirooka Y, Imaizumi T, Tagawa T, Shiramoto M, Endo T, Ando S, Takeshita A. Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure. Circulation 1994; 90:658-668.
27. Lieberman EH, Gerhard MD, Uehata A, Selwyn AP, Ganz P, Yeung AC, et al. Flow-induced vasodilation of the human brachial artery is impaired in patients < 40 years of age with coronary artery disease. Am J Cardiol 1996; 78:1210-1214.
28. Sinoway LI, Musch TI, Minotti JR, Zelis R. Enhanced maximal metabolic vasodilatation in the dominant forearms of tennis players. J Appl Physiol 1986; 61:673-678.
29. de Divitiis M, Rubba P, Di Somma S, Liguori V, Galderisi M, Montefusco S, et al. Effects of short-term reduction in serum cholesterol with simvastatin in patients with stable angina pectoris and mild to moderate hypercholesterolemia. Am J Cardiol 1996; 78:763-768.
30. Holven KB, Holm T, Aukrust P, Christensen B, Kjekshus J, Andreassen AK, et al. Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects. Am J Med 2001; 110:536-542.
31. Sanada M, Higashi Y, Nakagawa K, Sasaki S, Kodama I, Sakashita T, et al. Oral estrogen replacement therapy increases forearm reactive hyperemia accompanied by increases in serum levels of nitric oxide in postmenopausal women. Gynecol Endocrinol 2001; 15:150-157.
32. Diamond SL, Eskin SG, McIntire LV. Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells. Science 1989; 243:1483-1485.
33. Brown NJ, Gainer JV, Stein CM, Vaughan DE. Bradykinin stimulates tissue plasminogen activator release in human vasculature. Hypertension 1999; 33:1431-1435.
34. Minai K, Matsumoto T, Horie H, Ohira N, Takashima H, Yokohama H, Kinoshita M. Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 2001; 37:1565-1570.
35. Coats P, Johnston F, MacDonald J, McMurray JJ, Hillier C. Endothelium-derived hyperpolarizing factor: identification and mechanisms of action in human subcutaneous resistance arteries. Circulation 2001; 103:1702-1708.
36. Costa F, Sulur P, Angel M, Cavalcante J, Haile V, Christman B, Biaggioni I. Intravascular source of adenosine during forearm ischemia in humans: implications for reactive hyperemia. Hypertension 1999; 33:1453-1457.
37. Hegeman RJ, van den Eijnden-Schrauwen Y, Emeis JJ. Adenosine 3 ′:5 ′-cyclic monophosphate induces regulated secretion of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells. Thromb Haemost 1998; 79:853-858.
38. Blais C Jr, Marceau F, Rouleau JL, Adam A. The kallikrein-kininogenkinin system: lessons from the quantification of endogenous kinins. Peptides 2000; 21:1903-1940.
39. Hornig B, Kohler C, Drexler H. Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans. Circulation 1997; 95:1115-1118.
40. Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 1990; 81:1762-1767.
41. Pedrinelli R, Dell'Omo G, Bandinelli S, Penno G, Mariani M. Transvascular albumin leakage and endothelial-mediated vasodilation in essential hypertension. Am J Hypertens 2000; 13:256-261.